Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1992 1
1997 1
1999 1
2001 1
2002 2
2009 1
2010 2
2011 1
2012 2
2013 3
2014 3
2015 3
2016 3
2017 2
2018 2
2019 5
2020 4
2021 1
2022 1
2023 1
2024 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. Among authors: truffinet p. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
Natural autoantibodies in schizophrenia.
Galinowski A, Barbouche R, Truffinet P, Louzir H, Poirier MF, Bouvet O, Loo H, Avrameas S. Galinowski A, et al. Among authors: truffinet p. Acta Psychiatr Scand. 1992 Mar;85(3):240-2. doi: 10.1111/j.1600-0447.1992.tb08602.x. Acta Psychiatr Scand. 1992. PMID: 1561897
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data.
Goldman MD, LaRocca NG, Rudick RA, Hudson LD, Chin PS, Francis GS, Jacobs A, Kapoor R, Matthews PM, Mowry EM, Balcer LJ, Panzara M, Phillips G, Uitdehaag BMJ, Cohen JA; Multiple Sclerosis Outcome Assessments Consortium. Goldman MD, et al. Neurology. 2019 Nov 19;93(21):e1921-e1931. doi: 10.1212/WNL.0000000000008519. Epub 2019 Oct 22. Neurology. 2019. PMID: 31641014 Free PMC article.
39 results